OncLive Polls Spotlight Phase 3 Breast Cancer Studies Generating Buzz Ahead of ASCO 2025

AI Identifies Novel Biomarker for Aggressive Breast Cancer

A landmark study led by researchers at the National Institutes of Health has identified a new tissue-based biomarker, stromal disruption, that may help predict the risk of developing aggressive breast cancer and forecast survival outcomes. Published in JNCI: Journal of the National Cancer Institute, the study leveraged machine learning to analyze over 9,000 breast tissue samples, revealing microenvironmental patterns previously invisible to path…

OncLive Polls Spotlight Phase 3 Breast Cancer Studies Generating Buzz Ahead of ASCO 2025

Breast cancer experts rank key abstracts of interest from the upcoming ASCO Annual Meeting on OncLive’s social media.

Scientists design a new molecule to fight aggressive breast cancer

Research Matters Staff Writer(s) Hyderabad 16 May 2025 Breast cancer remains a significant challenge, particularly in aggressive forms like triple-negative breast cancer (TNBC). This is a type of breast cancer where the tumour cells lack hormonal receptors, like estrogen receptors. This means that common breast cancer treatments targeting these receptors are not effective against TNBC, making it more challenging to treat and prone to spreading. …